Institutional investors purchased a net $1.6 million shares of SRPT during the quarter ended June 2016, and now own 66.30% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 239.2 Thousand shares of Sarepta Therapeutics Inc